ClinicalTrials.gg
RecruitingNCT06133673Updated Nov 24, 2023

KSS Autism: Parameters and Future Care

An observational study in Autism, Autism Spectrum Disorder and Quality of Life, sponsored by Sussex Community NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 6 Years to 16 Years. Per ClinicalTrials.gov, last updated 2023-11-24.

Sponsored by Sussex Community NHS Foundation Trust · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
6 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies in Autistic Disorder with a site in United Kingdom — 10 open to participants now, 14 under way, none of them phase 3. Autistic Disorder · United Kingdom.

Planned enrollment
12th of 16
30 · median 163
Started
2023
with 4 others
Observational
16 of 37
4 open now
Primary completion
2024-09
later than 2 of 13 live
Registered
25th of 37
by date
Lead sponsor
4 of 37
Sussex Community NHS Foundation Trust

Among the 37 studies in Autistic Disorder with a site in United Kingdom, this one is the 12th largest by planned enrollment of the 16 observational ones that give a count, is one of 5 that started in 2023, is one of 16 observational ones, reaches primary completion later than 2 of the 13 other live ones, and was the 25th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

10 of the 37 studies in Autistic Disorder with a site in United Kingdom are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 6 Years to 16 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Autistic Disorder with a site in United Kingdom, or all of them as a file.
02

Study summary

Referrals for autism assessment have greatly increased in the last few years. This means that waiting times are longer for families, and children and young people are struggling to get the support they need. This also means that the number of autistic children and young people there is assumed to be is not correct. A better understanding of the true number of autistic children and young people is needed so that better support for them can be provided.

This research aims to understand what autism looks like in Kent, Surrey, and Sussex (KSS) to better help autistic children and young people. To do this, schools will be asked about the number of autistic children in their school to better understand the number of children and young people with autism in KSS. Secondly, autistic children and young people will be interviewed to find out about the support they need. The information gathered will help the research team to develop a quality-of-life measure, which can be used by schools to help autistic children and young people get the support they need.

Read the detailed description

Referrals for autism assessment in the UK have significantly increased in recent years, with mean referral rates doubling between 2015 and 2019. With it taking a year or more to reach a diagnostic conclusion, leaving autistic children and young people unidentified and without access to support they desperately need.

Delays in assessment and diagnosis can be exacerbated in areas of hidden deprivation, including marginalised coastal and cities, as well as rural communities. Delayed diagnosis and complex co-occurring mental health conditions lead to poor lifelong outcomes. With early recognition and diagnosis, early intervention can create more impactful changes in the lives of autistic children.

One area with hidden deprivation is Kent, Surrey and Sussex (KSS), though this area has not been investigated for its prevalence rates. Lack of prevalence investigations across KSS mean few interventions understand local autism changes, and listening to children will tell us about their own lived experience. Current evidence either investigates aspects of autism prevalence using older diagnostic criteria, is comparative looking at co-occurring conditions, or simply reports numbers referred. What is not known are current rates across primary schools, as many studies focus on secondary school transition or experiences.

Initial work by Tebruegge carried out a retrospective investigation only in the Maidstone area of Kent by asking all headteachers to report all children with an established diagnosis of autism. Leekam used KSS children as a Language Impairment comparison group. Department of Health in a broader Kent, East Sussex and South-East London Boroughs investigation reported highest quantiles for prevalence for those diagnosed. Prior work by this research team found that one area of West Sussex has seen autism referrals between 2015-2019 increase annually from 61 to 225 (269% increase). Interviews with Special Educational Needs Coordinators (SENCos) conducted by this research team and the Born in Bradford study suggest that a significant number of children in schools with symptoms of autism are not going through the diagnostic process.

The nationwide Clinical Practice Research Datalink (CPRD) primary care database makes a historical understanding of autism problematic, as codes and diagnostic symptoms change over time. Russell shows autism from 1998 to 2018 involves the use of no less than 16 clinical codes. This makes reference to these codes as difficult, hence our change of view from clinical records to current report from schools. However, children with potential autism or social communication issues are referred by General Practitioners, health visitors, Speech and Language Therapists, school nurses, preschool staff, and schoolteachers. It is unusual to accept referrals from parents directly. Within school-based populations there is relative under-diagnosis amongst children from Reception (4 to 5 Years) to Year 6 (10 to 11 years). Children in the age bracket of 6-8 have symptoms that become more apparent as peers overtake social communication abilities as social interaction and school-based play and communication leap in complexity. This makes their needs more apparent. The referrals continue to increase in the age bracket of 8-11, as the social communication gap continues to widen, especially in girls. With this increase, a better estimate of autism prevalence in the KSS area is needed.

With both referrals and needs of autistic children increasing, other areas of their lives are impacted. Evidence does suggest that having autism can negatively impact autistic children's outcomes in later life, for example, living independently, job employment and retention, having social relationships, experiencing poor mental health and quality-of-life. Despite this, there is limited evidence of a measure of quality of life for autistic children to help with their unmet needs and overall quality-of-life in school.

Mulraney and Coghill reported on the commonly used quality-of-life measures used in children (with ADHD). This includes the Pediatric Quality of Life Inventory (PedsQL) and the Child Health and Illness Profile (CHIP-CE). These measures look at the general functioning of children, such as social, emotional, and physical functioning. Though these questionnaires have been used to look at the quality-of-life in children with ADHD, they do not look at autism, and there is no quality-of-life measure specifically for autistic children. Most studies of quality-of-life of high-functioning autistic children have utilized the PedsQL.

For adults, there is a measure of quality-of-life known as the Autism Quality of Life Measure. The ASQoL is a 9-item measure, designed with autistic people in mind, by autistic people, who participated in the development of the measure. However, it was only designed as an add-on to other QoL measure, the World Health Organisation Quality of Life Measure (WHOQoL), the WHO-BREF and the WHO Disabilities module. Thus, this measure is used in conjunction with other QoL measures, suggesting that there is no standalone quality-of-life measure for autistic people. Also, this measure is used in autistic adults, again suggesting that there is no one single quality-of-life for autistic children.

Given the evidence around outcomes for autistic adults, it seems paramount to intervene early, and give autistic children the ability to have their own say in their needs to improve their quality-of-life. It would be beneficial to have a quality-of-life measure specifically for autistic children to improve their future outcomes. Children's views and suggestions on their own care are therefore vital, yet are rarely gathered, which the research team aim to address by modifying the ASQoL, a validated questionnaire which identifies priorities for Quality of Life and Wellbeing for autistic adults, for autistic children to address their needs in school and help them to advocate for their own support.

03

Conditions studied

  • Autism
  • Autism Spectrum Disorder
  • Quality of Life
04

Who can participate

Ages eligible
6 Years to 16 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

20 schools across Kent, Surrey and Sussex (KSS) will take part in completing a questionnaire to ascertain autism prevalence in KSS. 10 children and young people (CYP) will take part in an interview to find out about their needs in school to inform a quality of life questionnaire to be used by CYP and school staff in schools.

Eligibility criteria

For the survey, the inclusion criteria are:

  • Primary and secondary schools in Kent, Surrey and Sussex

For the CYP interviews, the inclusion criteria are:

  • Aged 6-16
  • Attends a school in Kent, Surrey and Sussex
  • Autism diagnosis

For the survey, the exclusion criteria includes:

  • Nurseries
  • Higher education schools
  • Schools outside of Kent, Surrey and Sussex

For the CYP interviews, the exclusion criteria includes:

  • Children outside of 6-16 age range
  • Children without autism diagnosis
  • Non-verbal children
  • Parent/carer unable or unwilling to agree for their child to take part
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Schools

    Prevalence questionnaire data will be collected from 20 schools.

  • Autistic children and young people (CYP)

    10 semi-structured qualitative interviews will be conducted with autistics CYP.

06

What researchers measure

Primary outcomes

  1. Prevalence questionnaire

    A 6-item non-validated questionnaire that will be used to ask schools about the number of children on their school roll, the number of children with a diagnosis of autism and also other neurodevelopmental conditions.

    Time frame: 5 minutes

07

Study locations

1 of 1 sites recruiting
  • Sussex Community NHS Foundation Trust
    Brighton, BN2 3EW, United Kingdom
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2023 (actual). Primary completion is estimated for Sep 2024, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2023
First posted
Nov 15, 2023
StartActual
Sep 18, 2023
Primary completionEst.
Sep 18, 2024
CompletionEst.
Sep 18, 2024
Last update
Nov 24, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06133673
Lead sponsor
Sussex Community NHS Foundation Trust
Responsible party
Sponsor
First posted
Nov 15, 2023
Start date
Sep 18, 2023
Primary completion
Sep 18, 2024 (estimated)
Completion
Sep 18, 2024 (estimated)
Last update
Nov 24, 2023

Study contacts

Helen Vaughan
Contact
helenvaughan@nhs.net
44 1273 696011
Sophie McGrevey
principal investigator · Sussex Community NHS FT

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion